Acknowledgements:
To the parents of these children and the nurses of the pediatric unit of Nylon district hospital and Mother and Child Center Yaounde.
Competing interest: None to declare
REFERENCES
1. Forlino A, Marini JC. Osteogenesis imperfecta. Lancet Lond Engl. 2016;387(10028):1657‑71.
2. Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe AD, et al. Osteogenesis imperfecta. Nat Rev Dis Primer. 2017;3:17052.
3. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101‑16.
4. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet Lond Engl. 2004;363(9418):1377‑85.
5. Kaboré A, Cissé A, Yonaba C, Savadogo H, Ouédraogo SA, Dao L, et al. Ostéogenèse imparfaite: à propos de quatre cas à Ouagadougou (Burkina Faso). Pan Afr Med J [Internet]. 2015 [cité 16 juin 2019]. Disponible sur: https://www.panafrican-med-journal.com/content/article/22/69/full/
6. Antoniazzi F, Mottes M, Fraschini P, Brunelli PC, Tatò L. Osteogenesis Imperfecta. Paediatr Drugs. 2000;2(6):465‑88.
7. Lee DY, Cho T-J, Choi IH, Chung CY, Yoo WJ, Kim JH, et al. Clinical and Radiological Manifestations of Osteogenesis Imperfecta Type V. J Korean Med Sci. 2006;21(4):709‑14.
8. Harrington J, Sochett E, Howard A. Update on the evaluation and treatment of osteogenesis imperfecta. Pediatr Clin North Am. 2014;61(6):1243‑57.
9. Dwan K, Phillipi CA, Steiner RD, Basel D. Bisphosphonate therapy for osteogenesis imperfecta. Cochrane Database Syst Rev. 2016;10:CD005088.
10. Garganta MD, Jaser SS, Lazow MA, Schoenecker JG, Cobry E, Hays SR, et al. Cyclic bisphosphonate therapy reduces pain and improves physical functioning in children with osteogenesis imperfecta. BMC Musculoskelet Disord [Internet]. 2018 [cité 16 juin 2019];19. Disponible sur: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154399/